During disease pathology, AD-related PSEN mutations have been shown to accelerate the catalytic proteolysis of APP by γ-secretase, resulting in the increased production of longer, amyloidogenic Aβ peptides (Kabir et al., 2020). Here, APP is linked to Alzheimer disease.